Checkpoint blockade is a single targeted immunotherapy that only solves a hurdle of workstation on T cells, may be ineffective for cold tumor, and may induce acquired drug resistance of hot tumor through a vicious circle due to the effect of IFN-γ secreted from reactivated CD8+ T cells. This evidence concerns the gene IFNG and neoplasm.